Aster DM Quality Care Ltd submits revised Q2/H1 FY27 investor presentation, reporting Q2 revenue of ₹2,829 crore and operating EBITDA of ₹678 crore
- Q2 revenue rose 19% year-on-year; operating EBITDA increased 25%, with a 24.0% margin, up 111 bps.
- Normalised PAT was ₹281 crore, up 34% year-on-year, excluding merger-related exceptional expenses and losses from equity-accounted investees.
- Q2 synergies reached ₹16.6 crore, with a ₹65 crore annualised run-rate against ₹200 crore full potential; revision corrected an inadvertently misstated workforce number. Results are unaudited and based on a limited review.
